The 2026 Breakthrough Prize honored advances in dark matter, quantum physics, gene editing and nonlinear mathematics.

Four NAS members have been announced as 2026 Breakthrough Prize Laureates. Jean Bennett and Katherine High have been awarded ...

Accelerated concussion recovery rates of this magnitude have broad implications for public health, workforce productivity, and contact sports. COLORADO SPRINGS, Colo., Feb. 10, 2026 /PRNewswire/ -- ...

Findings showed in the rinatabart sesutecan 100mg/m 2 cohort, the confirmed ORR was 50%, with 2 patients achieving complete response. The Food and Drug Administration (FDA) has granted Breakthrough ...

Treatment with TSND-201 was associated with statistically significant improvement in PTSD symptoms. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TSND-201 ...

Sonrotoclax, a BCL2 inhibitor, received FDA breakthrough therapy designation for relapsed or refractory mantle cell lymphoma, indicating its potential to transform patient outcomes. The drug is ...

Sofetabart mipitecan received FDA breakthrough therapy designation for platinum-resistant ovarian cancer after prior bevacizumab and mirvetuximab soravtansine treatment. Preliminary phase 1a/b study ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration’s breakthrough program has made a steady start to the 2026 financial year, granting designations ...